STAT3 and gastric cancer: In the future, the widespread adoption of advanced techniques, such as flow cytometry, immunofluorescence labeling, and single-cell sequencing, could enable the detection of gastric cancer stem cells and their associated markers (e.g., Cripto-1, STAT3, and p63) in biopsy samples obtained via endoscopy.